Logo

Liposomes Market Size, Share, and Growth Forecast 2026 - 2033

Liposomes Market by Product (Simple Liposomes, Formulated Liposomes: Doxorubicin, Amphotericin B, Paclitaxel, Cytarabine Liposomes; Vaccines), Application (Drug Delivery: Cancer, Fungal Infection, Viral & Parasite Infection, Others; Gene Delivery/Transfection; Contrast Agents for Medical Imaging; Model Cell Membranes), End-user (Hospitals, Specialty Clinics, Research Institutes, Pharmaceutical & Biotechnology Companies, Cosmetic Industry), and Regional Analysis, 2026 - 2033

ID: PMRREP16546
Calendar

June 2026

196 Pages

Author : Pravin Rewale

Healthcare
  1. Executive Summary
    1. Global Liposomes Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Value Chain Analysis
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
    4. Forecast Factors - Relevance and Impact
    5. Product Adoption Analysis
    6. PESTLE Analysis
    7. Porter's Five Forces Analysis
    8. Regulatory and Technology Landscape
  3. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. Global Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Global Liposomes Market Outlook: Product
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Product, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Product, 2026-2033
        1. Simple Liposomes
        2. Formulated Liposomes
          1. Doxorubicin Liposomes
          2. Amphotericin B Liposomes
          3. Paclitaxel Liposomes
          4. Cytarabine Liposomes
          5. Others
        3. Vaccines
      4. Market Attractiveness Analysis: Product
    3. Global Liposomes Market Outlook: Application
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Application, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Application, 2026-2033
        1. Drug delivery
          1. Cancer
          2. Fungal Infection
          3. Viral & Parasite Infection
          4. Others
        2. Gene Delivery/Transfection
        3. Contrast agents for medical imaging
        4. Model Cell Membranes
      4. Market Attractiveness Analysis: Application
    4. Global Liposomes Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
        1. Hospitals
        2. Specialty Clinics
        3. Research Institutes
        4. Pharmaceutical & Biotechnology Companies
        5. Cosmetic Industry
      4. Market Attractiveness Analysis: End User
  5. Global Liposomes Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. North America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  7. Europe Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. Europe Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  8. East Asia Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. East Asia Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  9. South Asia & Oceania Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  10. Latin America Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. Latin America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  11. Middle East & Africa Liposomes Market Outlook: Historical (2020 - 2025) and Forecast (2026 - 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Simple Liposomes
      2. Formulated Liposomes
        1. Doxorubicin Liposomes
        2. Amphotericin B Liposomes
        3. Paclitaxel Liposomes
        4. Cytarabine Liposomes
        5. Others
      3. Vaccines
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Drug delivery
        1. Cancer
        2. Fungal Infection
        3. Viral & Parasite Infection
        4. Others
      2. Gene Delivery/Transfection
      3. Contrast agents for medical imaging
      4. Model Cell Membranes
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Hospitals
      2. Specialty Clinics
      3. Research Institutes
      4. Pharmaceutical & Biotechnology Companies
      5. Cosmetic Industry
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Novartis AG (Liposoma BV)
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. Precision NanoSystems Inc
      3. Janssen Pharmaceutical Companies (Johnson & Johnson)
      4. Encapsula Nano Sciences
      5. Synpac-Kingdom Pharmaceutical Co., Ltd
      6. Celsion GmbH
      7. Gilead Sciences, Inc
      8. Pacira BioSciences, Inc.
      9. Luye Pharma Group
      10. Sun Pharma Industries Ltd
      11. Shanghai New Asia Pharmaceutical Co., Ltd.
      12. ENERGY DELIVERY SOLUTIONs
      13. Creative Biolabs
      14. Nanovex Biotechnologies SL
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -